Clinical Trials on Interface Acceptance During Delivery of Aerosol Medicine to an Infant or Child in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
- Hospital Samaritano Paulista
- JMI Laboratories
- Hazelden Betty Ford Foundation
- Dr. Praveen B.H
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Prof. Jacques SCHRENZEL
- Physip S.A
- Pedro Gamito
- Familien Hede Nielsens Fond
- Custom Pharmaceuticals Limited
- Fogarty International Center of the National Institute of Health
- Nestlé Health Science Belgium
- UZ Leuven, campus Pellenberg (Belgium)
- Markham Stouffville Hospital
- The Fred Hollows Foundation, Australia
- IN-JET APS
- Advanced Life Solutions
- Janssen (China) Research & Development Center
- Stannah Stairlifts
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- View Full List
Medical Conditions
- Chlamydophila Infections
- Closure; Foramen Ovale
- Epidemic Hemorrhagic Fever
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Ewing's Family Tumors
- Painless Hysteroscopy
- Gullian Barre Syndrome
- Fetus or Neonate Affected by External Version Before Labor
- Multisystem Proteinopathy
- Psoriasis, Arthritic
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Spine Surgeries
- Fracture Dislocation of Cervical Spine
- Predictors of Atrial Fibrillation Recurrences
- Skull Base Neoplasms
- Endocarditis Infective
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Childhood Langerhans Cell Histiocytosis
- Pulmonary Adenocarcinoma
- Tay-Sachs Disease Ganglioside
- View Full List
Drug Interventions
- Glimepiride
- Cereport
- Adapalene Gel 0.3%
- Semapimod
- Adriamycin
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Palliative care group first-line scheme
- Azelastine hydrochloride (BAYR9258)
- EFV +TVA
- Chemotherapeutic Agent
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Qingkailing injection 40 ml
- Esomeprazole 40mg before
- Vehicle
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Redifferentiation with retinoid acid
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- High dose pantoprazole infusion
- Neihulizumab
- Estradiol+Drospirenone
- View Full List
CROs by country
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Italy
- Contract Research Organizations in Japan
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Mali
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Saudi Arabia
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Zambia
- CRO list by country